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Inhaled formaldehyde is classified as a known human and
animal carcinogen, causing nasopharyngeal cancer. Additionally,
limited epidemiological evidence for leukemia in humans is
available; however, this is inconsistent across studies. Both
genotoxicity and cytotoxicity are key events in formaldehyde
nasal carcinogenicity in rats, but mechanistic data for leukemia
are not well established. Formation of DNA adducts is a key event
in initiating carcinogenesis. Formaldehyde can induce DNA
monoadducts, DNA-DNA cross-links, and DNA protein cross-
links. In this study, highly sensitive liquid chromatography-
tandem mass spectrometry-selected reaction monitoringmethods
were developed and [13CD2]-formaldehyde exposures utilized,
allowing differentiation of DNA adducts and DNA-DNA cross-
links originating from endogenous and inhalation-derived
formaldehyde exposure. The results show that exogenous
formaldehyde induced N2-hydroxymethyl-dG monoadducts and
dG-dG cross-links in DNA from rat respiratory nasal mucosa but
did not form [13CD2]-adducts in sites remote to the portal of entry,
even when five times more DNA was analyzed. Furthermore, no
N6-HO13CD2-dA adducts were detected in nasal DNA. In
contrast, high amounts of endogenous formaldehyde dG and dA
monoadducts were present in all tissues examined. The number of
exogenous N2-HO13CD2-dG in 1- and 5-day nasal DNA samples
from rats exposed to 10-ppm [13CD2]-formaldehyde was 1.28 ± 0.49
and 2.43 ± 0.78 adducts/107 dG, respectively, while 2.63 ± 0.73 and
2.84 ± 1.13 N2-HOCH2-dG adducts/10
7 dG and 3.95 ± 0.26 and
3.61 ± 0.95 N6-HOCH2-dA endogenous adducts/10
7 dA were
present. This study provides strong evidence supporting a genotoxic
and cytotoxic mode of action for the carcinogenesis of inhaled
formaldehyde in respiratory nasal epithelium but does not support
the biological plausibility that inhaled formaldehyde also causes
leukemia.
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Formaldehyde is a known human and animal carcinogen
according to the International Agency for Research on Cancer
(IARC, 2006), causing nasopharyngeal cancer in humans and
squamous cell carcinomas in the nasal respiratory epithelium of
rats and mice (Kerns et al., 1983; Monticello et al., 1996;
Swenberg et al., 1980). Associations between formaldehyde
exposure and the induction of leukemia were identified in
epidemiology studies of professional and industrial workers.
However, this finding was only positive when peak exposure
but not cumulative exposure was used as the exposure metric
and was not consistent across studies (Coggon et al., 2003;
Hauptmann et al., 2003, 2004). A recent follow-up of the
epidemiology study of U.S. industrial workers also found an
association between peak exposure to formaldehyde with the
induction of leukemia, especially myeloid leukemia (Beane
Freeman et al., 2009). Whether or not formaldehyde causes
leukemia remains debatable, as no consistent experimental data
provide mechanistic insight on the induction of leukemia,
although several possible mechanisms have been proposed
(Zhang et al., 2009a; Zhang et al., 2009b) and some possible
support for the induction of leukemia in humans has been
published (Zhang et al., 2010).
The association between formaldehyde exposure and the
induction of leukemia has raised the question whether inhaled
formaldehyde can reach remote tissues such as bone marrow to
cause genotoxicity. Formation of DNA adducts and increased
cell proliferation secondary to cytotoxicity are well-established
key events that drive the induction of nasal cancer in rats by
formaldehyde (IARC, 2006). Formaldehyde readily induces
DNA protein cross-links (DPCs) in nasal epithelial DNA of
rats (Casanova-Schmitz and Heck, 1983), the site of contact
following inhalation exposure; however, DPC have not been
demonstrated in tissues remote from the portal of entry
(Casanova-Schmitz et al., 1984). DPC measurements have
utilized non–chemical-specific methods, primarily based on
physical chemistry. Chemical-specific DNA biomarkers have
not been evaluated following inhalation exposure to formalde-
hyde, a primary route of exposure. Thus, the present study is
the first study to examine inhalation-specific DNA adducts of
formaldehyde.
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Formaldehyde’s well-known toxicity and carcinogenicity
and wide spread human exposure has raised public concern
over its safety. Formaldehyde can directly enter into the body
through environmental exposure such as vehicle emissions, off-
gassing of building materials, food, tobacco smoke and indoor
air, such as living in FEMA trailers (http://www.cdc.gov/nceh
/ehhe/trailerstudy). Formaldehyde can also be indirectly gener-
ated through metabolism of a variety of compounds including
nutrients, drugs, and proteins by demethylation. Of equal
importance, formaldehyde is an essential metabolic intermedi-
ate in all living cells and is endogenously produced from
serine, glycine, methionine, and choline. The endogenous
concentration of formaldehyde in the blood of human subjects
is about 0.1mM (IARC, 2006). Therefore, the presence of both
endogenous and exogenous formaldehyde makes developing
chemical-specific biomarkers to monitor the molecular dose of
inhaled formaldehyde exposure and understand its toxicity
especially challenging.
Several previous in vitro studies demonstrated that
N6-hydroxymethyl-dA (N6-HOCH2-dA) was a primary form-
aldehyde-DNA monoadduct (McGhee and von Hippel, 1975;
Zhong and Hee, 2004; Zhong and Que Hee, 2004). Recently,
the Hecht laboratory reported increased amounts of
N6-HOCH2-dA in multiple tissues of rats treated with
N-nitrosodimethylamine (NDMA) or 4-(methylnitrosamino)-
1-(3-pyridyl)-1-butanone (NNK) (Cheng et al., 2008; Wang
et al., 2007), which were attributed to the production of
formaldehyde during the metabolism of NDMA and NNK.
More recently, they have demonstrated clear differences in the
amounts of formaldehyde-induced N6-HOCH2-dA in leuko-
cytes of smokers and nonsmokers (Wang et al., 2009). Thus,
N6-HOCH2-dA may serve as a good biomarker for formalde-
hyde exposure after inhalation. In preliminary cell culture
experiments, we found that N2-hydroxymethyl-dG was also
a suitable DNA biomarker for formaldehyde exposure.
Therefore, in the present study, we measured both
N2-hydroxymethyl-dG and N6-hydroxymethyl-dA in tissues
of rats exposed by inhalation to 10-ppm [13CD2]-formaldehyde
for 6 h or for 5 days (6 h/day). Exposures for the present study
were modeled after the 10-ppm exposure data from a previous
cancer bioassay where it was clearly carcinogenic (Monticello
et al., 1996), induced marked increases in sustained cell
proliferation, yet was less cytotoxic than 15-ppm formalde-
hyde. The use of [13CD2]-formaldehyde permitted the
simultaneous measurement of both endogenous and exogenous
formaldehyde-DNA adducts in any tissue using sensitive liquid
chromatography-electrospray ionization-tandem mass
spectrometry-selected reaction monitoring (LC-ESI-MS/
MS-SRM) methods to detect and quantify formaldehyde-
induced DNA adducts and DNA-DNA cross-links (Fig. 1).
The data generated in this study provide critical information to
understand formaldehyde’s toxicity, carcinogenicity, and
the biological plausibility of leukemia induction following
inhalation exposure to formaldehyde.
MATERIALS AND METHODS
Chemicals and materials. Deoxyguanosine, deoxyadenine, potassium
phosphate, Tris-HCl, MgCl2, formic acid, NaCNBH3, methanol, acetonitrile,
high-performance liquid chromatography (HPLC)–grade water, and 103 PBS
were all purchased from Sigma (St Louis, MO); 20% formaldehyde in water was
procured from Tousimis (Rockville, MD). DNaseI, alkaline phosphatase, and
phosphodiesterases were purchased from Sigma. [15N5]-dA and [
13C10
15N5]-dG
were ordered from Cambridge Isotope Laboratories, Inc. (Cambridge, MA).
N6-CH3-dA and N
2-CH3-dG were obtained from Sigma and Berry & Associates
(Dexter, MI), respectively. All chemicals were used as received unless otherwise
stated.
High-performance liquid chromatography. The purification of
formaldehyde-DNA adducts was carried out on an Agilent 1200 series HPLC
system equipped with a diode-array detector (Santa Clara, CA). Analytes in
30- to 200-lg DNA hydrolysate were separated by reverse-phase chromatog-
raphy using a 150- 3 2.5-mm T3 analytical column from Waters (Milford,
MA). The mobile phases were 0.1% formic acid (A) and methanol (B). A linear
gradient was run from 2% methanol to 30% methanol over 30 min, at a flow
rate of 200 ll/min and monitored at 254 nm. N6-Me-dA and N2-Me-dG eluted
at 22.2 and 25.2 min on the column in this system, respectively, and dG-dG
cross-links eluted at 34.3 min with a linear gradient from 2 to 60% methanol
over 60 min, at a flow rate of 200 ll/min.
The LC-MS. LC-MS analyses were performed on a triple-quadrupole
mass spectrometer Ultra TSQ-Quantum (Thermo Electron, Waltham, MA)
operating in SRM mode to detect and quantify formaldehyde-DNA adducts.
The mass spectrometer was interfaced with an ultra-performance liquid
chromatography (UPLC) system from Waters. A 150- 3 1.0-mm T3 column
(3-lm particle size) from Waters was used. A linear gradient was run from
2% methanol in 0.1% aqueous formic acid to 60% methanol over 10 min, at
40 ll/min. For the analysis of monoadducts, the ESI source was set as follows:
spray voltage, 4.0 kV; capillary temperature, 300C; sheath gas pressure, 40 au;
aux gas pressure, 10 au. For the analysis of dG-CH2-dG, the mass spectrometer
was coupled with a Waters nanoAcquity LC system. A 100-mm 3 100-lm
nanoAcquity UPLC HSS T3 column was used. A linear gradient was run from
2% acetonitrile in 0.1% acetic acid to 50% in 10 min, at a flow rate at 0.6 or
1 ll/min. The ESI source was set as follows: spray voltage, 2.2–2.5 kV;
capillary temperature, 280C.
Preparation of internal standards. 10 mM [13C10
15N5]-dG and [
15N5]-dA
solution was treated by 100mM formaldehyde in phosphate buffer (pH ¼ 7.2)
overnight at 37C. The reaction mixture was separated by HPLC using a 150- 3
2.5-mm C18 T3 analytical column. N2-hydroxymethyl-dG and N6-
hydroxymethyl-dA eluted at 20.5 and 24.3 min, respectively. N2-hydroxy-
methyl-dG and N6-hydroxymethyl-dA were collected and incubated with 50mM





6-CH3-dA eluted at 27.2 and
33.5 min on a 150- 3 2.5-mm T3 column using 10mM ammonium acetate in





6-CH3-dA was determined by HPLC with
unlabeled N6-CH3-dA and N
2-CH3-dG as references. The usual conversion rate
from hydroxymethyl group to methyl group was 65–85%. The internal standard
of dG-dG cross-links was prepared by incubating 10mM [13C10
15N5]-dG with
100mM formaldehyde in phosphate buffer (pH ¼ 7.2) for 96 h at 37C. The
dG-dG cross-links eluted at 34.3 min using a linear gradient from 2% methanol in
0.1% formic acid to 60% methanol over 60 min, at a flow rate of 200 ll/min.
Animal exposures. Test atmospheres of formaldehyde were generated by
the thermal depolymerization of [13CD2]-paraformaldehyde (CAS No. 30525-
89-4) obtained from Cambridge Isotopes Laboratories, Inc. Confirmation of
the [13CD2]-paraformaldehyde purity and identity was accomplished using
gas chromatography-mass spectrometry. The test atmospheres of [13CD2]-
formaldehyde were generated from an 80-l Teflon bag using a peristaltic pump
to deliver vaporized [13CD2]-formaldehyde into the nose-only chamber supply
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airflow. [13CD2]-Formaldehyde exposure atmospheres were measured by
a calibrated infrared spectrophotometer (IR) (MIRAN 1A; The Foxboro Co.,
Foxboro, MA) with the IR sampling the concentration prior to entering the
nose-only chamber. The IR was calibrated using the chromotropic acid assay;
a wet chemistry method for the measurement of formaldehyde concentrations.
The estimated limit of detection for the IR was 0.02 ppm/0.005 V.
Animal use in this study was approved by the Institutional Animal Use and
Care Committee of The Hamner Institutes for Health Sciences and was
conducted in accordance with the National Institutes of Health guidelines for
the care and use of laboratory animals. Animals were housed in fully accredited
American Association for Accreditation of Laboratory Animal Care facilities.
Male Fischer 344 rats were exposed to 10-ppm [13CD2]-formaldehyde
atmospheres for 1 or 5 days (6 h/day) using a single nose-only unit (Lab
Products, Seaford, DE). One nose-only unit was used for all exposures. The air
supply was controlled with a mass flow controller to maintain a total air flow
that assured at least 2.5 times the estimated minute ventilation (0.20 ml/min) for
a 250-g rat or ~0.5 l/min at each open port. The air supply for 30 rats was
maintained at ~15 l/min. Temperature was measured near the center top of the
chamber by a Pre-Con All Purpose Thermister Sensor, Model ST-A (Kele &
Associates, Memphis, TN), connected to the Andover Building Automation
System. Calibration was performed by comparing the thermister probe to
a certified mercury thermometer. The mean of the hourly readings and SD for
the 1-day exposure was 74.7 ± 0.6F, while the mean of the daily mean and SD
for the 5-day exposure was 69.2 ± 1.1F for the target of 72F. Relative
humidity was measured near the center top of the chamber by a Rotronic
Humidity Sensor (Series 1200; Rotronic Instrument Corp., Huntington, NY)
connected to the Andover Building Automation System. The relative humidity
sensor was calibrated by immersing the probe in an atmosphere of known
humidity generated from saturated salt solutions. The mean of the hourly
readings and SD for the 1-day exposure was 40.3 ± 1.4%, while the mean of the
daily mean and SD for the 5-day exposure was 50.6 ± 3% for the target of 50%.
Animals were anesthetized with Nembutal (50–60 mg/kg) i.p. within 2 h of
the end of exposure; 3–5 ml of blood was collected by cardiac puncture for
lymphocyte isolation. Nasal respiratory epithelium from the right and left sides
of the nose and from the septum was collected, as were entire tissues of spleen,
thymus, lung, and liver. Bone marrow was collected from both femurs by saline
extrusion with a large bore needle. Tissue samples were collected and
immediately frozen on dry ice followed by storage at 80C.
DNA isolation and digestion. DNA was isolated from the tissues of rats
using a NucleoBond DNA isolation kit (Bethlehem, PA), as instructed by the
manufacturer with small modifications. The resultant DNA was quantified
and stored at 80C for further analysis. DNA isolated from each nose
sample (~30–50 lg) was incubated with 50mM NaCNBH3 at 37C for 6 h in
phosphate buffer (pH ¼ 7.1). Then, DNA was treated by DNaseI (200 U) for
10 min in the digestion buffer (80mM Tris-HCl, 20mM MgCl2, pH ¼ 7.2),
followed by the addition of 25 ll of alkaline phosphatase and 25 ll of
phosphodiesterases for an additional hour. Enzymes and undigested DNA were
removed by a Millipore Microcon YM-10 spin column for 45 min at 23C, and
the resultant solution was separated by HPLC to collect the fractions containing
FIG. 1. The formation of N2-hydroxymethyl-dG (A) and dG-dG cross-links (B) originating from both endogenous and exogenous formaldehyde.
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the corresponding DNA adducts. For monoadduct analysis of liver, lung, thymus,
bone marrow, and spleen, 200 lg of DNA was used for digestion using the same
methods. For monoadduct analysis of blood samples, DNA isolated from two to
three animals (60–100 lg) was pooled for further analysis. Typically, 10 ll of
hydrolysate was used to quantify dG and dA generated from DNA enzymatic
digestion.
Sample workup for DNA-DNA cross-links. For the analysis of dG-dG
cross-links in nose samples, 30–50 lg isolated nasal DNA was digested
enzymatically as described above in Tris buffer for 70 min at 37C, followed
by a cleaning procedure with a Millipore Microcon YM-10 spin column for
45 min at 23C. NaCNBH3 was not used in DNA isolation for dG-dG cross-
link analysis as it labilized the cross-links. The hydrolysate, after removing
10 ll for dG quantitation, was frozen at 20C and separated by HPLC after
12 h storage. A parallel control experiment was carried out, to determine the
extent of artifact. We spiked an equal amount of isotope-labeled [13C10
15N5]-dG,
as was produced from DNA digestion (determined by HPLC with UV detector
using a small aliquot of DNA solution), into the sample before hydrolysis.
Thus, the signal corresponding to cross-links dG-CH2-[
13C10
15N5]-dG
accounted for approximately half of the artifacts formed during sample workup
and storage, which demonstrated the amount of artifactual dG-CH2-dG
formed during sample workup and storage. The extent of artifact was
determined using the integrated peak area of dG-CH2-[
13C10
15N5]-dG
divided by the peak area of dG-CH2-dG. For the analysis of dG-dG cross-
links in other tissues, 200 lg DNA was digested for 70 min at 37C, followed
by a cleaning procedure with a Millipore Microcon YM-10 spin column for
60 min at 4C. The resultant solution was frozen on dry ice immediately,
followed by the storage in 80C.
Quantitation of formaldehyde-DNA adducts. The adducts were quanti-
fied by a triple-quadrupole mass spectrometer Ultra TSQ-Quantum (Thermo
Electron) using SRM mode. N2-HOCH2-dG was quantified as N
2-CH3-dG after
reduction with NaCNBH3 using the transition of m/z 282.2 / m/z 166.1 and
N2-HO13CD2-dG was quantified as N
2-13CD2H-dG with the transition of m/z
285.2 / m/z 169.1. In addition, transitions were applied simultaneously to
monitor possible precursors including m/z 284.2 and 283.2 which could arise
from hydrogen-deuterium exchange of [13CD2]-formaldehyde. N
6-HOCH2-dA
was detected as N6-CH3-dA after treatment by NaCNBH3 with the transition of
m/z 266.2/ m/z 150.1, while N6-HO13CD2-dA was monitored with the
transition of m/z 269.2 / m/z 153.1 after reduction. Similarly, two additional
transitions for m/z 268.2 and 267.2 were used to monitor possible ions arising
as a consequence of hydrogen-deuterium exchange. The collision energy was
set at 17 V after optimization. dG-CH2-dG and dG-
13CD2-dG was detected and
quantified using the transition of m/z 547.5 to m/z 152.1 and m/z 550.5 to m/z
152.1, with the collision energy set at 23V. The calibration curves for
quantitation were obtained using the integrated peak area and amount of
injected analytical standard and internal standard.
Statistical analysis of data. Data represent mean ± SD. Unpaired
Student’s t-tests were performed using the SAS statistical package (SAS
Institute, Cary, NC) with the sample size ranging from 5 to 8 for monoadduct
analysis. Differences were considered statistically significant if p < 0.05.
RESULTS
Determination of Atmospheric Concentration of
Formaldehyde for Animal Exposures
The mean of the hourly readings and SD for the 1-day
exposure was 10.2 ± 0.5 ppm, while the mean of the daily mean
and SD for the 5-day exposure was 10.6 ± 0.2 ppm for the target
concentration of 10.0-ppm [13CD2]-formaldehyde in air.
Method Development for Analysis of Formaldehyde-Induced
Monoadducts
Highly sensitive methods for the analysis of N2-
hydroxymethyl-dG and N6-hydroxymethyl-dA were developed
that exhibited excellent precision and accuracy (Fig. 2 and
Table 1). Hydroxymethyl adducts were detected and quantified
as the corresponding stable methyl adducts after reduction with
NaCNBH3. The limit of detection for N
2-CH3-dG was ~240
amol on the column (S/N ¼ 3), while the limit of detection for
N6-CH3-dA was ~75 amol on the column (S/N ¼ 3). Sat-
isfactory accuracy and precision of this assay were shown
by adding known amounts of N2-CH3-dG and N
6-CH3-dA
analytical standards to 50 lg of DNA, as listed in Table 1.
Exogenous and Endogenous N2-Hydroxymethyl-dG Is
Formed in Nasal Respiratory DNA, but Exogenous
N2-HO13CD2-dG Is Not Formed in DNA at Sites Distant to
the Portal of Entry
Figure 3A shows the LC-ESI-MS/MS chromatogram of
N2-Me-dG in nasal DNA from a 1-day exposed rat. The peak
corresponding to the specific transition of m/z 282.2 / m/z
166.1 and the same retention time with the [13C10
15N5]-N
2-
CH3-dG internal standard unambiguously identified the
formation of N2-HOCH2-dG from endogenous formaldehyde,
FIG. 2. Typical LC-ESI-MS/MS-SRM chromatograms of 0.8 fmol of




on the column (A). 0.15 fmol of N6-CH3-dA and 37.5 fmol of internal standard
[15N5]-N
6-CH3-dA (B). Typical calibration curve used for the quantitation of
N2-Me-dG adducts (C). Typical calibration curves used for the quantitation of
N6-Me-dA adducts (D).
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as shown by the peak at 7.55 min in the top panel of Figure 3A.
In addition to the peak of endogenous adducts, a new peak
corresponding to the transition of m/z 285.2 / m/z 169.1
coeluted with the internal standard, which is consistent with
N2-HO13CD2-dG formed from exogenous [
13CD2]-formalde-
hyde. Similarly, both endogenous and exogenous dG adducts
could be clearly identified and quantified in 30–50 lg of
nasal epithelial DNA after 5 days of exposure, as shown in
Figure 3B. Compared with Figure 3A, the amount of exoge-
nous N2-HO13CD2-dG in nasal DNA increased as a consequence
of extended exposure. In all other tissues including liver, lung,
thymus, bone marrow, and spleen of 1- or 5-day exposed rats,
only endogenous formaldehyde-induced N2-HOCH2-dG could
be observed in 200 lg DNA. As shown by the middle panels of
Figures 3C and 3D, no signal corresponding to the transition of
m/z 285.2 / m/z 169.1 of exogenous adducts was present at
the same retention time with the internal standard. In addition,
two additional transitions to monitor m/z 284.2 and 283.2 did
not detect any exogenous dG adducts arising from hydrogen-
deuterium exchange. Therefore, there were no detectable
amounts of N2-HO13CD2-dG in sites remote to the portal of
entry after 1 or 5 days of exposure, despite the utilization of
fivefold more DNA for these tissues in an assay with a limit
of detection of ~240 amol on column for N2-HO13CD2-dG.
Endogenous N6-Hydroxymethyl-dA Is Present in All Tissues,
but Exogenous N6-HO13CD2-dA Is Not Present in Any Tissue
We then analyzed N6-hydroxymethyl-dA adducts in rats ex-
posed to 10-ppm [13CD2]-formaldehyde, as shown in Figure 4.
TABLE 1




Added Detecteda Accuracy (%) CV (%) Added Detected Accuracy (%) CV (%)
10 10.8 ± 0.7b 108 6 10 10.2 ± 0.5 102 5
20 22.5 ± 0.9 112 4 20 21.6 ± 1.2 108 5
40 42.3 ± 0.4 105 0.1 40 40.9 ± 1.4 102 3
aSample size n ¼ 3.
bMean ± SD.
FIG. 3. LC-ESI-MS/MS-SRM chromatograms of N2-Me-dG in typical tissues: 1-day exposed nasal respiratory epithelium (A), 5-day exposed nasal
respiratory epithelium (B), bone marrow (C), and spleen (D).
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Figures 4A and 4B illustrate the LC-ESI-MS/MS-SRM
chromatograms of N6-Me-dA in noses of rats exposed to
[13CD2]-formaldehyde for 1 or 5 days. The peak corresponding
to the specific transition of m/z 266.2 / m/z 150.1 and the
same retention time as the internal standard identified the
formation of N2-HOCH2-dA from endogenous formaldehyde.
However, there was no signal for N6-HO13CD2-dA (m/z 269.2
/ m/z 153.1). Figures 4C and 4D show the chromatograms of
N6-Me-dA in bone marrow and spleen of 5-day exposed rats.
Moreover, additional transitions to monitor m/z 268.2 and
267.2 did not identify any exogenous dA adducts generated
from hydrogen-deuterium exchange. Therefore, we did not
detect a peak for N6-HO13CD2-dA after [
13CD2]-formaldehyde
exposure in any tissue using an assay with a limit of detection
of ~75 amol on column, while we clearly observed the peak of
N6-HOCH2-dA from endogenous formaldehyde in all tissues.
These data show that N6-HOCH2-dA is not a good biomarker
for inhaled formaldehyde.
Table 2 summarizes the number of adducts in all the tissues
measured in this study. For 1-day exposed samples, endoge-
nous N2-HOCH2-dG ranged from 1.05 to 2.66 adducts/10
7 dG
depending on tissues, while endogenous N6-HOCH2-dA was
from 1.85 to 3.95 adducts/107 dA. For 5-day exposed rats, the
numbers of endogenous N2-HOCH2-dG and N
6-HOCH2-dA
were 1.10–3.24 adducts/107 dG and 2.23–3.66 adducts/107 dA,
respectively. It is of interest to note that endogenous
N6-HOCH2-dA was present in control rat liver at 1.96 ± 1.86
adducts/107 dA (Wang et al., 2007), which is similar to our
1-day (2.62 ± 0.46 adducts/107 dA) and 5-day (2.87 ± 0.65
adducts/107 dA) endogenous N6-HOCH2-dA in rat liver DNA.
Exogenous [13CD2]-formaldehyde exposure only induced
DNA adducts with dG, and this adduct was only detected in
nasal epithelium from 1- or 5-day exposed rats. The mean
amounts of exogenous N2-HO13CD2-dG in 1- or 5-day exposed
nasal epithelium samples were 1.28 ± 0.49 and 2.43 ± 0.78
adducts/107 dG, respectively (Fig. 5A, p < 0.05). The ratio of
exogenous versus endogenous N2-hydroxymethyl-dG is shown
in Figure 5B. There was a statistically significant difference
between 1-day and 5-day exposed samples (p < 0.05). The
former had a ratio of 0.57 ± 0.28, while the ratio of 5-day
exposed sample was 1.06 ± 0.40.
Endogenous dG-CH2-dG Cross-links Are Present in All
Tissues, but Exogenous dG-13CD2-dG Cross-links Are
Only Formed in Nasal DNA
A sensitive nano-LC-MS/MS-SRM method was also de-
veloped, with a limit of detection of ~60 amol on column, to
detect dG-CH2-dG cross-links in the tissue samples. Some
typical chromatograms are shown in Figure 6. Similar to the
monoadducts, the exogenous dG-13CD2-dG only could be
detected in nasal DNA (Figs. 6A and 6B) and not in DNA from
any distant tissue such as liver and spleen (Figs. 6C and 6D).
These data demonstrate that no detectable amounts of
exogenous dG-dG cross-links were induced at distant sites in
rats by inhalation exposure to formaldehyde.
The numbers of dG-dG cross-links in individual tissues are
also summarized in Table 2. The amount of endogenous cross-
links ranged from 0.09 to 0.21 adducts/107 dG across all
FIG. 4. LC-ESI-MS/MS-SRM chromatograms of N6-Me-dA of typical tissues of rats: nasal respiratory epithelium of a 1-day exposed rat (A), nasal respiratory
epithelium of a 5-day exposed rat (B), bone marrow of a 5-day exposed rat (C), and spleen of a 5-day exposed rat (D).
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tissues. In contrast, the amounts of exogenous dG-13CD2-dG
were 0.14 ± 0.06 and 0.26 ± 0.07 adducts/107 dG in DNA from
nasal epithelium of 1-day and 5-day exposed rats, respectively,
but were not detectable in other tissues. These numbers were
roughly 10% of the amount of corresponding monoadducts.
Since N2-hydroxymethyl-dG can further react with dG,
potential artifacts could form during sample workup and
storage. Therefore, we carried out a parallel control experiment
adding amounts of [13C10
15N5]-dG equal to the amount of dG
in the sample and determined that ~65% of the cross-links were
artifact by calculating the peak ratio under the conditions used
to analyze nose samples (Fig. 7). The data in Table 2 were
corrected to remove such artifact. Therefore, the data on dG-dG
cross-links were considered less rigorous than monoadduct
data due to the issue of potential artifacts. Special caution is
needed when generating or using quantitative data on
formaldehyde-induced dG-dG cross-links as the molecular
dosimeter. Nevertheless, no exogenous dG-dG cross-links were
detected in tissues remote to the portal of entry, even though
we utilized fivefold more DNA which increased our ability to
quantify true cross-link formation and formation from artifact.
DISCUSSION
This study addressed several critical issues related to
formaldehyde toxicity and carcinogenicity. Exogenous
N2-HO13CD2-dG was only detected in DNA from nasal
respiratory epithelium of rats after inhalation. The same was true
for exogenous dG-dG cross-links. The absence of exogenous
formaldehyde-induced DNA adducts and cross-links in other
TABLE 2
Formaldehyde-Induced Monoadducts and dG-dG Cross-links in Rats Exposed to 10-ppm Formaldehyde for 1 day or 5 daysa
Exposure period Tissues
N2-HOCH2-dG (adducts/10
7 dG) N6-HOCH2-dA (adducts/10
7 dA) dG-CH2-dG (adducts/10
7 dG)
Exogenous Endogenous Exogenous Endogenous Exogenous Endogenous
1 day Nose 1.28 ± 0.49b 2.63 ± 0.73 nd 3.95 ± 0.26 0.14 ± 0.06c 0.17 ± 0.05
Lung ndd 2.39 ± 0.16e nd 2.62 ± 0.24 nd 0.20 ± 0.04f
Liver nd 2.66 ± 0.53 nd 2.62 ± 0.46 nd 0.18 ± 0.05
Spleen nd 2.35 ± 0.31 nd 1.85 ± 0.19 nd 0.15 ± 0.06
Bone Marrow nd 1.05 ± 0.14 nd 2.95 ± 1.32 nd 0.09 ± 0.01
Thymus nd 2.19 ± 0.36 nd 2.98 ± 1.11 nd 0.10 ± 0.03
Bloodg nd 1.28 ± 0.38 nd 3.80 ± 0.29 nd 0.12 ± 0.09
5 day Nose 2.43 ± 0.78 2.84 ± 1.13 nd 3.61 ± 0.95 0.26 ± 0.07 0.18 ± 0.06
Lung nd 2.61 ± 0.35 nd 2.47 ± 0.55 nd 0.20 ± 0.03
Liver nd 3.24 ± 0.42 nd 2.87 ± 0.65 nd 0.21 ± 0.08
Spleen nd 2.35 ± 0.59 nd 2.23 ± 0.89 nd 0.16 ± 0.08
Bone Marrow nd 1.17 ± 0.35 nd 2.99 ± 0.08 nd 0.11 ± 0.03
Thymus nd 1.99 ± 0.30 nd 2.48 ± 0.11 nd 0.19 ± 0.03
Bloodg nd 1.10 ± 0.28 nd 3.66 ± 0.78 nd 0.10 ± 0.07
aThe limit of detection for dG monoadducts, dA monoadducts, and dG-dG cross-links was ~240, ~75, and ~60 amol, respectively.
bn ¼ 5–8 nose samples for the analysis of monoadducts in 30–50 lg of DNA; data represent mean ± SD.
cn ¼ 4–5 nose samples for the analysis of cross-links, artifacts have been subtracted from the data.
dNot detectable (nd) in 200 lg of DNA.
en ¼ 4–5 for distant tissues.
fn ¼ 3 for distant tissues.
g60–100 lg of DNA was typically used for analysis of white blood cells isolated from blood.
FIG. 5. The amount of exogenous N2-HO13CD2-dG in nasal respiratory
epithelial DNA of rats exposed to 10-ppm formaldehyde for 1 day or 5 days
(A). The ratio of exogenous versus endogenous N2-hydroxymethyl-dG for
1-day and 5-day exposed nasal respiratory epithelial DNA (B).
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tissues supports the conclusion that genotoxic effects of inhaled
formaldehyde are implausible at sites remote to the portal of
entry. Endogenous formaldehyde-induced N6-HOCH2-dA was
detected in all tissues, but N6-HO13CD2-dA was not detectable
in DNA from any tissue examined in rats exposed by inhalation
to [13CD2]-formaldehyde. It is important to note that previous
methods used to measure DPC (Casanova et al., 1994;
Casanova-Schmitz and Heck, 1983; Casanova-Schmitz et al.,
1984; Kato et al. 2001) and specific DNA adducts (Cheng
et al., 2008) could not differentiate between endogenous and
exogenous DNA damage. It was only through the use of the
[13CD2]-formaldehyde and mass spectrometry that endogenous
and exogenous adducts could specifically be measured
simultaneously in the same tissue. Furthermore, by monitoring
the transitions that would occur if there were any hydrogen-
deuterium exchange, we have demonstrated that neither inhaled
formaldehyde nor methanediol derived from inhaled formal-
dehyde reaches sites distant to the portal of entry.
In this study, we found that exogenous formaldehyde-
induced N2-hydroxymethyl-dG adducts and corresponding
dG-dG cross-links only formed in nasal DNA of rats exposed
to 10-ppm [13CD2]-formaldehyde by inhalation (Figs. 3 and 6).
These data support causation of nasal carcinoma following
exposure to formaldehyde by inhalation. Formaldehyde was
first identified as a carcinogen when rats exposed to 0, 2, 6,
or 15 ppm for up to 24 months developed squamous cell
carcinomas of the nasal passages (Kerns et al., 1983; Swenberg
et al., 1980). Nasal carcinomas developed in 51 males and
52 females exposed to 15-ppm rats but only in 1 male and
1 female rat exposed to 6-ppm formaldehyde. No malignant
tumors of the nose occurred in rats exposed to 2 ppm or in
controls (Kerns et al., 1983). A second carcinogenicity study
was conducted that expanded the exposure response to include
0.7-, 2-, 6-, 10-, and 15-ppm formaldehyde. Formaldehyde
induced nasal squamous cell carcinomas in a highly nonlinear
fashion, with no neoplasms at the lowest two concentrations
(0/90 animals for each group), and 1/90, 20/90, and 69/147
carcinomas in rats exposed to 6-, 10-, and 15-ppm formalde-
hyde (Monticello et al., 1996). In addition to the squamous cell
carcinomas, polypoid adenomas were present in 0/90 of the
control, 0.7-, 2-, and 6-ppm exposed rats and 5/90 and 14/147
animals exposed to 10- and 15-ppm formaldehyde. Cell
proliferation was also greatly increased at 10- and 15-ppm
exposures.
IARC recently classified formaldehyde as a known human
carcinogen based on sufficient evidence for nasopharyngeal
carcinoma (IARC, 2006). Extensive research has demonstrated
that both genotoxicity and cytotoxicity contribute to the car-
cinogenesis of formaldehyde in nasal tissues (IARC, 2006). As
mentioned above, marked and sustained increases in cell
proliferation in the noses of rats have been observed after
exposure to  10-ppm formaldehyde (Conolly et al., 2003a;
Monticello et al., 1996). In this study, we found that exogenous
formaldehyde-induced N2-hydroxymethyl-dG adducts and
corresponding dG-dG cross-links formed in nasal DNA of rats
after 10-ppm [13CD2]-formaldehyde exposure. These findings
FIG. 6. LC-ESI-MS/MS-SRM chromatograms of dG-dG cross-links in typical tissues of rats: nasal respiratory epithelium of a 1-day exposed rat (A), nasal
respiratory epithelium of a 5-day exposed rat (B), liver of a 5-day exposed rat (C), and spleen of a 5-day exposed rat (D). The exogenous dG-13CD2-dG only could
be detected in nasal respiratory epithelial DNA and not in DNA from any tissue remote from the portal of entry.
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provide new insight regarding how exposure to formaldehyde
may cause nasal cancer. Several guanine point mutations have
been identified by DNA sequence analysis of p53 cDNA from
formaldehyde-induced squamous cell carcinomas in nasal
passages of rats, including 398G / T, 638G / T, 812G / A,
and 842G / C (Recio et al., 1992). Earlier studies of Heck and
Casanova demonstrated a linear response for DPC between
formaldehyde exposures of 6 and 15 ppm but reduced numbers
of DPC per ppm formaldehyde at 2 and 0.7 ppm (Casanova-
Schmitz et al., 1984). The present study quantitated endoge-
nous dG adducts and dG-dG cross-links in numerous tissues,
including the nasal respiratory epithelium. It also quantitated the
number of endogenous dA adducts in these tissues. Surpris-
ingly, the number of total endogenous formaldehyde adducts
was greater than the number of exogenous adducts in nasal
DNA following exposures to 10-ppm [13CD2]-formaldehyde.
The number of endogenous formaldehyde adducts was similar
across tissues. This suggests that the marked increases in cell
proliferation induced by exposure to 10 and 15 ppm may play
a critical role in converting both endogenous and exogenous
labile but promutagenic adducts into mutations. At low
exposures (< 0.1 ppm), minimal numbers of exogenous
formaldehyde adducts will be formed relative to the high
number of endogenous formaldehyde adducts. Likewise, no
increase in cell proliferation has been associated with such low
exposures, so fewer adducts would result in mutations. Nasal
squamous cell carcinomas are rare in nonexposed rats but were
very prominent in rats exposed to 10- or 15-ppm formaldehyde.
This improved understanding of the mechanisms involved
strengthens the role of cytotoxicity-induced cell proliferation in
the mutagenesis and carcinogenesis of inhaled formaldehyde.
We have demonstrated that exogenous [13CD2]-
formaldehyde only induced DNA lesions at the site of contact
but not in DNA of distant organs (Figs. 3 and 6). This result
has strong implications regarding the plausibility of formalde-
hyde causing leukemia. Evidence for an association between
leukemia and formaldehyde exposure have been identified in
several epidemiology studies but were not present in others
(Coggon et al., 2003). Leukemia was increased in the U.S.
formaldehyde worker cohort only when the highest versus
lowest peak exposure were compared but not when cumulative
exposure was the metric (Beane Freeman et al., 2009).
Likewise, a meta-analysis found an increase in lymphohema-
topoietic malignancies, with the highest relative risk for
myeloid leukemia (Zhang et al., 2009b). In contrast, Coggon
found no association with leukemia in the British cohort, even
though 28% of the workers had exposures > 2.0 ppm (Coggon
et al., 2003). Previous studies suggested that it was not possible
to identify a mechanism for the induction of myeloid leukemia
in humans. For example, no increase has been found in the
formaldehyde concentration in the blood of exposed humans
and animals, there were no detectable protein adducts or DPC
in the bone marrow of rats exposed to as high as 15-ppm
formaldehyde, no DPC were detectable in the bone marrow of
Rhesus monkeys exposed to formaldehyde as high as 6 ppm,
and no chromosomal aberrations were found in the bone
marrow of rats exposed to as high as 15-ppm formaldehyde
(Heck and Casanova 2004). Recently, Zhang et al. hypothe-
sized three possible mechanisms for the induction of leukemia
by formaldehyde (Zhang et al., 2009b). First, formaldehyde
may act directly on the bone marrow. The present study
demonstrates that this does not occur. They then suggested that
hematopoietic stem cells/early progenitor cells in the circula-
tion, or residing in the nasal passages, could be exposed in the
nose, travel to the bone marrow, and be transformed into
leukemia cells. However, in this study, we did not detect any
exogenous formaldehyde-induced DNA adducts in white blood
cell samples although two times more DNA was used to
increase our ability to detect exogenous DNA damage. The
numbers of endogenous N2-HOCH2-dG and N
6-HOCH2-dA in
white blood cells were 1.10 to 1.28 adducts/107 dG and 3.66 to
3.80 adducts/107 dA, which is similar to other tissues we
examined. Our methods would have been able to detect ~3
N2-HO13CD2-dG adducts/10
9 dG, which is ~30 times less than
the number of endogenous N2-HOCH2-dG adducts present in
white blood cells. The fact that lung, spleen, liver, thymus, and
bone marrow did not have detectable HO13CD2-dG adducts in
FIG. 7. Formation of artifacts under the conditions used to analyze dG-dG
cross-links in nasal DNA samples. The extent of artifacts (~65%) was
determined by the area ratio of peak562.5/152.1 (middle panel) versus
peak547.5/152.1 (top panel) in parallel control experiments by adding amounts
of [13C10
15N5]-dG equal to the amount of dG in the sample during sample
workup and storage.
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200 lg of DNA suggests that the likelihood that this adduct
would be formed is even lower.
There are no data that support these later two mechanisms
for the induction of leukemia by any chemical. Furthermore,
circulating myeloid cells do not typically return to bone
marrow and proliferate (McKinney-Freeman and Goodell,
2004). Finally, the exogenous formaldehyde-DNA adducts are
labile and would not be expected to persist for more than a
day or so, based on our data for 1 versus 5 days of exposure
and in vitro experiments (Lu et al., 2010; Zhong and Hee,
2004). The cells containing labile adducts would need to travel
to the bone marrow and undergo cell division shortly after
being adducted. A recent paper by Zhang et al. (2010) suggests
that formaldehyde exposure disrupts hematopoietic function
and induces aneuploidy in cultured myeloid progenitor cells
from a small group of exposed workers. However, the methods
used in this study do not differentiate whether the chromosomal
changes were induced in vivo or in vitro. The possibility that
formaldehyde induces leukemia in humans cannot be totally
ruled out by this study due to well-known species differences
in airway architecture, ventilation rate, and breathing mode.
Humans could be differentially exposed to formaldehyde
through oronasal breathing, while rats are exposed through
obligatory nasal breathing. Although DPC were detected in
some regions of the upper respiratory tract in addition to the
turbinates and anterior lateral wall/septum of monkeys after
exposure to 6-ppm formaldehyde, no DPC were found in the
bone marrow, the sinuses, or in proximal lung of monkeys
(Casanova et al., 1991). Moreover, when using DPC as an end
point, the yield of DPC in the noses of monkeys was about an
order of magnitude lower than in the noses of rats. This was
attributed to species differences in minute volume and quantity
of exposed tissue (Casanova et al., 1991). In addition,
comprehensive analysis of nasal airflow and formaldehyde
transport in rat, monkey, and human by computational fluid
dynamic models coupled with dose-response predications
derived from a combined rodent and human data set indicated
that human cancer risks associated with inhaled formaldehyde
would be significantly lower at relevant human exposures
(Conolly et al., 2003b, 2004; Kimbell et al., 2001). Therefore,
our finding that exogenous N2-HO13CD2-dG adducts were only
formed in nasal DNA, that the DNA adducts are labile, and that
high numbers of endogenous formaldehyde adducts are always
present indicate that inhaled formaldehyde is unlikely to cause
leukemia. The data from this study may also be useful in
constructing a quantitative analysis of the likely flux in humans
at higher ventilation rates (Conolly et al., 2004).
In summary, the results of this study clearly demonstrated
that endogenous and exogenous formaldehyde-induced DNA
adducts and DNA-DNA cross-links could be unambiguously
differentiated utilizing [13CD2]-formaldehyde exposures and
mass spectrometry. This approach allowed us to quantitatively
examine the molecular dose of endogenous and exogenous
formaldehyde-DNA adducts in a multitude of tissues following
inhalation exposure. Moreover, we demonstrated that exoge-
nous formaldehyde-induced N2-HO13CD2-dG is the primary
DNA monoadduct in rats exposed by inhalation to 10-ppm
[13CD2]-formaldehyde for 1 day or 5 days. This provides clear
evidence that inhaled formaldehyde induced exposure-specific
DNA adducts at the target site for carcinogenesis. More
importantly, we have shown that exogenous formaldehyde-
induced DNA monoadducts and dG-dG cross-links only occur
in rat nasal mucosa, providing clear evidence that genotoxic
effects at sites remote to the portal of entry of inhaled
formaldehyde are implausible. The data generated in this study
add greatly to our understanding of the toxicity and
carcinogenicity of formaldehyde, a high-volume chemical of
intense public health concern.
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